Cardio Diagnostics Holdings (CDIO) Return on Sales (2022 - 2026)
Cardio Diagnostics Holdings (CDIO) posted Return on Sales of 6.67% for Q1 2026, down 61.87% sequentially from 4.12% in Q4 2025, and up 1072.0% YoY from 0.57% in Q1 2025.
Cardio Diagnostics Holdings (CDIO) Return on Sales (2022 - 2026) Analysis & Trends
Cardio Diagnostics Holdings has reported Return on Sales for 5 years, with the latest figure at 6.67% in Q1 2026.
- Quarterly Return on Sales rose 1072.0% year-over-year to 6.67% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.02% (down 107.0% YoY) and the FY2025 annual result came in at 3.46%, down 106.0% from the prior year.
- Return on Sales retreated to 6.67% in Q1 2026 per CDIO's latest filing, from 4.12% in the prior quarter.
- Over five years, Return on Sales peaked at 1.64% in Q2 2024 and troughed at 56.88% in Q1 2023.
- A 5-year average of 11.14% and a median of 3.74% in 2024 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2024 and 2025: Return on Sales jumped 5427 bps in 2024, then sank 1478 bps in 2025.
- Over 5 years, Return on Sales stood at 25.03% in 2022, then soared by 90 bps to 2.62% in 2023, then slipped by 29 bps to 3.37% in 2024, then slipped by 22 bps to 4.12% in 2025, then slumped by 62 bps to 6.67% in 2026.
- According to Business Quant data, Return on Sales over the past three periods registered 6.67%, 4.12%, and 6.01% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Cardio Diagnostics Holdings | 6.42 Mn | 835,350.96 | - | -2.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.80% |
| Mar 31, 2026 | -6.67% |
| Dec 31, 2025 | -4.12% |
| Sep 30, 2025 | -6.01% |
| Jun 30, 2025 | -2.25% |
| Mar 31, 2025 | -17.39% |
| Dec 31, 2024 | -3.37% |
| Sep 30, 2024 | -2.15% |
| Jun 30, 2024 | -1.64% |
| Mar 31, 2024 | -2.61% |
| Dec 31, 2023 | -2.62% |
| Sep 30, 2023 | -1.93% |
| Jun 30, 2023 | -23.32% |
| Mar 31, 2023 | -56.88% |
| Dec 31, 2022 | -25.03% |